TL;DR AI-generated French drug agency ANSM is informing 1.6 million women about an increased risk of developing meningioma when taking the contraceptive Desogestrel. The risk doubles after seven years of use compared to non-users.

TL;DR AI-generated Eckart von Hirschhausen calls a new weight loss pill, available in Germany since September, a "gamechanger." However, he stresses it does not solve fundamental issues like obesity prevention or societal structures, noting high prices charged by manufacturers in Germany.

TL;DR AI-generated A study of over 133,000 diabetes patients found that GLP-1 medications reduced the risk of fragility fractures by 21 percent. This lower fracture risk was observed regardless of changes in weight or blood sugar levels.

TL;DR AI-generated At the World AIDS Conference, Doctors Without Borders called for a lower price for the drug Lenacapavir, used for HIV prevention. The organization advocates for more affordable access to HIV protection measures.

TL;DR AI-generated A study indicates that individuals undergoing GLP-1 therapy experience a minor, yet tangible, increase in the risk of hair loss. This risk is notably higher when compared to other diabetes medications.